1 Neuraminidase Inhibitor Market Overview 1.1 Neuraminidase Inhibitor Product Scope 1.2 Neuraminidase Inhibitor Segment by Type 1.2.1 Global Neuraminidase Inhibitor Sales by Type (2016 & 2021 & 2027) 1.2.2 Zanamivir 1.2.3 Oseltamivir 1.2.4 Peramivir 1.2.5 Laninamivir 1.3 Neuraminidase Inhibitor Segment by Application 1.3.1 Global Neuraminidase Inhibitor Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Hospital Pharmacies 1.3.3 Drug Stores 1.3.4 Retail Stores 1.3.5 Others 1.4 Neuraminidase Inhibitor Market Estimates and Forecasts (2016-2027) 1.4.1 Global Neuraminidase Inhibitor Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Neuraminidase Inhibitor Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Neuraminidase Inhibitor Price Trends (2016-2027) 2 Neuraminidase Inhibitor Estimates and Forecasts by Region 2.1 Global Neuraminidase Inhibitor Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Neuraminidase Inhibitor Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Neuraminidase Inhibitor Sales Market Share by Region (2016-2021) 2.2.2 Global Neuraminidase Inhibitor Revenue Market Share by Region (2016-2021) 2.3 Global Neuraminidase Inhibitor Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Neuraminidase Inhibitor Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Neuraminidase Inhibitor Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Neuraminidase Inhibitor Estimates and Projections (2016-2027) 2.4.2 Europe Neuraminidase Inhibitor Estimates and Projections (2016-2027) 2.4.3 China Neuraminidase Inhibitor Estimates and Projections (2016-2027) 2.4.4 Japan Neuraminidase Inhibitor Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Neuraminidase Inhibitor Estimates and Projections (2016-2027) 2.4.6 India Neuraminidase Inhibitor Estimates and Projections (2016-2027) 3 Global Neuraminidase Inhibitor Competition Landscape by Players 3.1 Global Top Neuraminidase Inhibitor Players by Sales (2016-2021) 3.2 Global Top Neuraminidase Inhibitor Players by Revenue (2016-2021) 3.3 Global Neuraminidase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuraminidase Inhibitor as of 2020) 3.4 Global Neuraminidase Inhibitor Average Price by Company (2016-2021) 3.5 Manufacturers Neuraminidase Inhibitor Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Neuraminidase Inhibitor Market Size by Type 4.1 Global Neuraminidase Inhibitor Historic Market Review by Type (2016-2021) 4.1.1 Global Neuraminidase Inhibitor Sales Market Share by Type (2016-2021) 4.1.2 Global Neuraminidase Inhibitor Revenue Market Share by Type (2016-2021) 4.1.3 Global Neuraminidase Inhibitor Price by Type (2016-2021) 4.2 Global Neuraminidase Inhibitor Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Neuraminidase Inhibitor Sales Forecast by Type (2022-2027) 4.2.2 Global Neuraminidase Inhibitor Revenue Forecast by Type (2022-2027) 4.2.3 Global Neuraminidase Inhibitor Price Forecast by Type (2022-2027) 5 Global Neuraminidase Inhibitor Market Size by Application 5.1 Global Neuraminidase Inhibitor Historic Market Review by Application (2016-2021) 5.1.1 Global Neuraminidase Inhibitor Sales Market Share by Application (2016-2021) 5.1.2 Global Neuraminidase Inhibitor Revenue Market Share by Application (2016-2021) 5.1.3 Global Neuraminidase Inhibitor Price by Application (2016-2021) 5.2 Global Neuraminidase Inhibitor Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Neuraminidase Inhibitor Sales Forecast by Application (2022-2027) 5.2.2 Global Neuraminidase Inhibitor Revenue Forecast by Application (2022-2027) 5.2.3 Global Neuraminidase Inhibitor Price Forecast by Application (2022-2027) 6 North America Neuraminidase Inhibitor Market Facts & Figures 6.1 North America Neuraminidase Inhibitor Sales by Company 6.1.1 North America Neuraminidase Inhibitor Sales by Company (2016-2021) 6.1.2 North America Neuraminidase Inhibitor Revenue by Company (2016-2021) 6.2 North America Neuraminidase Inhibitor Sales Breakdown by Type 6.2.1 North America Neuraminidase Inhibitor Sales Breakdown by Type (2016-2021) 6.2.2 North America Neuraminidase Inhibitor Sales Breakdown by Type (2022-2027) 6.3 North America Neuraminidase Inhibitor Sales Breakdown by Application 6.3.1 North America Neuraminidase Inhibitor Sales Breakdown by Application (2016-2021) 6.3.2 North America Neuraminidase Inhibitor Sales Breakdown by Application (2022-2027) 7 Europe Neuraminidase Inhibitor Market Facts & Figures 7.1 Europe Neuraminidase Inhibitor Sales by Company 7.1.1 Europe Neuraminidase Inhibitor Sales by Company (2016-2021) 7.1.2 Europe Neuraminidase Inhibitor Revenue by Company (2016-2021) 7.2 Europe Neuraminidase Inhibitor Sales Breakdown by Type 7.2.1 Europe Neuraminidase Inhibitor Sales Breakdown by Type (2016-2021) 7.2.2 Europe Neuraminidase Inhibitor Sales Breakdown by Type (2022-2027) 7.3 Europe Neuraminidase Inhibitor Sales Breakdown by Application 7.3.1 Europe 136 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 136 Sales Breakdown by Application (2022-2027) 8 China Neuraminidase Inhibitor Market Facts & Figures 8.1 China Neuraminidase Inhibitor Sales by Company 8.1.1 China Neuraminidase Inhibitor Sales by Company (2016-2021) 8.1.2 China Neuraminidase Inhibitor Revenue by Company (2016-2021) 8.2 China Neuraminidase Inhibitor Sales Breakdown by Type 8.2.1 China Neuraminidase Inhibitor Sales Breakdown by Type (2016-2021) 8.2.2 China Neuraminidase Inhibitor Sales Breakdown by Type (2022-2027) 8.3 China Neuraminidase Inhibitor Sales Breakdown by Application 8.3.1 China 241 Sales Breakdown by Application (2016-2021) 8.3.2 China 241 Sales Breakdown by Application (2022-2027) 9 Japan Neuraminidase Inhibitor Market Facts & Figures 9.1 Japan Neuraminidase Inhibitor Sales by Company 9.1.1 Japan Neuraminidase Inhibitor Sales by Company (2016-2021) 9.1.2 Japan Neuraminidase Inhibitor Revenue by Company (2016-2021) 9.2 Japan Neuraminidase Inhibitor Sales Breakdown by Type 9.2.1 Japan Neuraminidase Inhibitor Sales Breakdown by Type (2016-2021) 9.2.2 Japan Neuraminidase Inhibitor Sales Breakdown by Type (2022-2027) 9.3 Japan Neuraminidase Inhibitor Sales Breakdown by Application 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Neuraminidase Inhibitor Market Facts & Figures 10.1 Southeast Asia Neuraminidase Inhibitor Sales by Company 10.1.1 Southeast Asia Neuraminidase Inhibitor Sales by Company (2016-2021) 10.1.2 Southeast Asia Neuraminidase Inhibitor Revenue by Company (2016-2021) 10.2 Southeast Asia Neuraminidase Inhibitor Sales Breakdown by Type 10.2.1 Southeast Asia Neuraminidase Inhibitor Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Neuraminidase Inhibitor Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Neuraminidase Inhibitor Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Neuraminidase Inhibitor Market Facts & Figures 11.1 India Neuraminidase Inhibitor Sales by Company 11.1.1 India Neuraminidase Inhibitor Sales by Company (2016-2021) 11.1.2 India Neuraminidase Inhibitor Revenue by Company (2016-2021) 11.2 India Neuraminidase Inhibitor Sales Breakdown by Type 11.2.1 India Neuraminidase Inhibitor Sales Breakdown by Type (2016-2021) 11.2.2 India Neuraminidase Inhibitor Sales Breakdown by Type (2022-2027) 11.3 India Neuraminidase Inhibitor Sales Breakdown by Application 11.3.1 India Neuraminidase Inhibitor Sales Breakdown by Application (2016-2021) 11.3.2 India Neuraminidase Inhibitor Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Neuraminidase Inhibitor Business 12.1 GlaxoSmithKline 12.1.1 GlaxoSmithKline Corporation Information 12.1.2 GlaxoSmithKline Business Overview 12.1.3 GlaxoSmithKline Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GlaxoSmithKline Neuraminidase Inhibitor Products Offered 12.1.5 GlaxoSmithKline Recent Development 12.2 Gilead Sciences 12.2.1 Gilead Sciences Corporation Information 12.2.2 Gilead Sciences Business Overview 12.2.3 Gilead Sciences Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Gilead Sciences Neuraminidase Inhibitor Products Offered 12.2.5 Gilead Sciences Recent Development 12.3 F. Hoffman-La Roche 12.3.1 F. Hoffman-La Roche Corporation Information 12.3.2 F. Hoffman-La Roche Business Overview 12.3.3 F. Hoffman-La Roche Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.3.4 F. Hoffman-La Roche Neuraminidase Inhibitor Products Offered 12.3.5 F. Hoffman-La Roche Recent Development 12.4 BioCryst 12.4.1 BioCryst Corporation Information 12.4.2 BioCryst Business Overview 12.4.3 BioCryst Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.4.4 BioCryst Neuraminidase Inhibitor Products Offered 12.4.5 BioCryst Recent Development 12.5 Daiichi Sankyo 12.5.1 Daiichi Sankyo Corporation Information 12.5.2 Daiichi Sankyo Business Overview 12.5.3 Daiichi Sankyo Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Daiichi Sankyo Neuraminidase Inhibitor Products Offered 12.5.5 Daiichi Sankyo Recent Development ... 13 Neuraminidase Inhibitor Manufacturing Cost Analysis 13.1 Neuraminidase Inhibitor Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Neuraminidase Inhibitor 13.4 Neuraminidase Inhibitor Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Neuraminidase Inhibitor Distributors List 14.3 Neuraminidase Inhibitor Customers 15 Market Dynamics 15.1 Neuraminidase Inhibitor Market Trends 15.2 Neuraminidase Inhibitor Drivers 15.3 Neuraminidase Inhibitor Market Challenges 15.4 Neuraminidase Inhibitor Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Neuraminidase Inhibitor Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Neuraminidase Inhibitor Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Neuraminidase Inhibitor Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Neuraminidase Inhibitor Sales (K Units) by Region (2016-2021) Table 5. Global Neuraminidase Inhibitor Sales Market Share by Region (2016-2021) Table 6. Global Neuraminidase Inhibitor Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Neuraminidase Inhibitor Revenue Share by Region (2016-2021) Table 8. Global Neuraminidase Inhibitor Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Neuraminidase Inhibitor Sales Market Share Forecast by Region (2022-2027) Table 10. Global Neuraminidase Inhibitor Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Neuraminidase Inhibitor Revenue Share Forecast by Region (2022-2027) Table 12. Global Neuraminidase Inhibitor Sales (K Units) of Key Companies (2016-2021) Table 13. Global Neuraminidase Inhibitor Sales Share by Company (2016-2021) Table 14. Global Neuraminidase Inhibitor Revenue (US$ Million) by Company (2016-2021) Table 15. Global Neuraminidase Inhibitor Revenue Share by Company (2016-2021) Table 16. Global Neuraminidase Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuraminidase Inhibitor as of 2020) Table 17. Global Neuraminidase Inhibitor Average Price (US$/Unit) of Key Company (2016-2021) Table 18. Manufacturers Neuraminidase Inhibitor Manufacturing Sites and Area Served Table 19. Manufacturers Neuraminidase Inhibitor Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Neuraminidase Inhibitor Sales (K Units) by Type (2016-2021) Table 22. Global Neuraminidase Inhibitor Sales Share by Type (2016-2021) Table 23. Global Neuraminidase Inhibitor Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Neuraminidase Inhibitor Price (US$/Unit) by Type (2016-2021) Table 25. Global Neuraminidase Inhibitor Sales Share by Type (2022-2027) Table 26. Global Neuraminidase Inhibitor Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Neuraminidase Inhibitor Revenue Share by Type (2022-2027) Table 28. Global Neuraminidase Inhibitor Price (US$/Unit) by Type (2022-2027) Table 29. Global Neuraminidase Inhibitor Sales (K Units) by Application (2016-2021) Table 30. Global Neuraminidase Inhibitor Sales Share by Application (2016-2021) Table 31. Global Neuraminidase Inhibitor Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Neuraminidase Inhibitor Price (US$/Unit) by Application (2016-2021) Table 33. Global Neuraminidase Inhibitor Sales (K Units) by Application (2022-2027) Table 34. Global Neuraminidase Inhibitor Sales Share by Application (2022-2027) Table 35. Global Neuraminidase Inhibitor Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Neuraminidase Inhibitor Revenue Share by Application (2022-2027) Table 37. Global Neuraminidase Inhibitor Price (US$/Unit) by Application (2022-2027) Table 38. North America Neuraminidase Inhibitor Sales (K Units) by Company (2016-2021) Table 39. North America Neuraminidase Inhibitor Sales Market Share by Company (2016-2021) Table 40. North America Neuraminidase Inhibitor Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Neuraminidase Inhibitor Revenue Market Share by Company (2016-2021) Table 42. North America Neuraminidase Inhibitor Sales by Type (2016-2021) & (K Units) Table 43. North America Neuraminidase Inhibitor Sales Market Share by Type (2016-2021) Table 44. North America Neuraminidase Inhibitor Sales by Type (2022-2027) & (K Units) Table 45. North America Neuraminidase Inhibitor Sales Market Share by Type (2022-2027) Table 46. North America Neuraminidase Inhibitor Sales by Application (2016-2021) & (K Units) Table 47. North America Neuraminidase Inhibitor Sales Market Share by Application (2016-2021) Table 48. North America Neuraminidase Inhibitor Sales by Application (2022-2027) & (K Units) Table 49. North America Neuraminidase Inhibitor Sales Market Share by Application (2022-2027) Table 50. Europe Neuraminidase Inhibitor Sales (K Units) by Company (2016-2021) Table 51. Europe Neuraminidase Inhibitor Sales Market Share by Company (2016-2021) Table 52. Europe Neuraminidase Inhibitor Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Neuraminidase Inhibitor Revenue Market Share by Company (2016-2021) Table 54. Europe Neuraminidase Inhibitor Sales by Type (2016-2021) & (K Units) Table 55. Europe Neuraminidase Inhibitor Sales Market Share by Type (2016-2021) Table 56. Europe Neuraminidase Inhibitor Sales by Type (2022-2027) & (K Units) Table 57. Europe Neuraminidase Inhibitor Sales Market Share by Type (2022-2027) Table 58. Europe Neuraminidase Inhibitor Sales by Application (2016-2021) & (K Units) Table 59. Europe Neuraminidase Inhibitor Sales Market Share by Application (2016-2021) Table 60. Europe Neuraminidase Inhibitor Sales by Application (2022-2027) & (K Units) Table 61. Europe Neuraminidase Inhibitor Sales Market Share by Application (2022-2027) Table 62. China Neuraminidase Inhibitor Sales (K Units) by Company (2016-2021) Table 63. China Neuraminidase Inhibitor Sales Market Share by Company (2016-2021) Table 64. China Neuraminidase Inhibitor Revenue by Company (2016-2021) & (US$ Million) Table 65. China Neuraminidase Inhibitor Revenue Market Share by Company (2016-2021) Table 66. China Neuraminidase Inhibitor Sales by Type (2016-2021) & (K Units) Table 67. China Neuraminidase Inhibitor Sales Market Share by Type (2016-2021) Table 68. China Neuraminidase Inhibitor Sales by Type (2022-2027) & (K Units) Table 69. China Neuraminidase Inhibitor Sales Market Share by Type (2022-2027) Table 70. China Neuraminidase Inhibitor Sales by Application (2016-2021) & (K Units) Table 71. China Neuraminidase Inhibitor Sales Market Share by Application (2016-2021) Table 72. China Neuraminidase Inhibitor Sales by Application (2022-2027) & (K Units) Table 73. China Neuraminidase Inhibitor Sales Market Share by Application (2022-2027) Table 74. Japan Neuraminidase Inhibitor Sales (K Units) by Company (2016-2021) Table 75. Japan Neuraminidase Inhibitor Sales Market Share by Company (2016-2021) Table 76. Japan Neuraminidase Inhibitor Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Neuraminidase Inhibitor Revenue Market Share by Company (2016-2021) Table 78. Japan Neuraminidase Inhibitor Sales by Type (2016-2021) & (K Units) Table 79. Japan Neuraminidase Inhibitor Sales Market Share by Type (2016-2021) Table 80. Japan Neuraminidase Inhibitor Sales by Type (2022-2027) & (K Units) Table 81. Japan Neuraminidase Inhibitor Sales Market Share by Type (2022-2027) Table 82. Japan Neuraminidase Inhibitor Sales by Application (2016-2021) & (K Units) Table 83. Japan Neuraminidase Inhibitor Sales Market Share by Application (2016-2021) Table 84. Japan Neuraminidase Inhibitor Sales by Application (2022-2027) & (K Units) Table 85. Japan Neuraminidase Inhibitor Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Neuraminidase Inhibitor Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Neuraminidase Inhibitor Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Neuraminidase Inhibitor Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Neuraminidase Inhibitor Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Neuraminidase Inhibitor Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Neuraminidase Inhibitor Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Neuraminidase Inhibitor Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Neuraminidase Inhibitor Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Neuraminidase Inhibitor Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Neuraminidase Inhibitor Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Neuraminidase Inhibitor Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Neuraminidase Inhibitor Sales Market Share by Application (2022-2027) Table 98. India Neuraminidase Inhibitor Sales (K Units) by Company (2016-2021) Table 99. India Neuraminidase Inhibitor Sales Market Share by Company (2016-2021) Table 100. India Neuraminidase Inhibitor Revenue by Company (2016-2021) & (US$ Million) Table 101. India Neuraminidase Inhibitor Revenue Market Share by Company (2016-2021) Table 102. India Neuraminidase Inhibitor Sales by Type (2016-2021) & (K Units) Table 103. India Neuraminidase Inhibitor Sales Market Share by Type (2016-2021) Table 104. India Neuraminidase Inhibitor Sales by Type (2022-2027) & (K Units) Table 105. India Neuraminidase Inhibitor Sales Market Share by Type (2022-2027) Table 106. India Neuraminidase Inhibitor Sales by Application (2016-2021) & (K Units) Table 107. India Neuraminidase Inhibitor Sales Market Share by Application (2016-2021) Table 108. India Neuraminidase Inhibitor Sales by Application (2022-2027) & (K Units) Table 109. India Neuraminidase Inhibitor Sales Market Share by Application (2022-2027) Table 110. GlaxoSmithKline Corporation Information Table 111. GlaxoSmithKline Description and Business Overview Table 112. GlaxoSmithKline Neuraminidase Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 113. GlaxoSmithKline Neuraminidase Inhibitor Product Table 114. GlaxoSmithKline Recent Development Table 115. Gilead Sciences Corporation Information Table 116. Gilead Sciences Description and Business Overview Table 117. Gilead Sciences Neuraminidase Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 118. Gilead Sciences Neuraminidase Inhibitor Product Table 119. Gilead Sciences Recent Development Table 120. F. Hoffman-La Roche Corporation Information Table 121. F. Hoffman-La Roche Description and Business Overview Table 122. F. Hoffman-La Roche Neuraminidase Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 123. F. Hoffman-La Roche Neuraminidase Inhibitor Product Table 124. F. Hoffman-La Roche Recent Development Table 125. BioCryst Corporation Information Table 126. BioCryst Description and Business Overview Table 127. BioCryst Neuraminidase Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 128. BioCryst Neuraminidase Inhibitor Product Table 129. BioCryst Recent Development Table 130. Daiichi Sankyo Corporation Information Table 131. Daiichi Sankyo Description and Business Overview Table 132. Daiichi Sankyo Neuraminidase Inhibitor Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 133. Daiichi Sankyo Neuraminidase Inhibitor Product Table 134. Daiichi Sankyo Recent Development Table 135. Production Base and Market Concentration Rate of Raw Material Table 136. Key Suppliers of Raw Materials Table 137. Neuraminidase Inhibitor Distributors List Table 138. Neuraminidase Inhibitor Customers List Table 139. Neuraminidase Inhibitor Market Trends Table 140. Neuraminidase Inhibitor Market Drivers Table 141. Neuraminidase Inhibitor Market Challenges Table 142. Neuraminidase Inhibitor Market Restraints Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Neuraminidase Inhibitor Product Picture Figure 2. Global Neuraminidase Inhibitor Sales Market Share by Type in 2021 & 2027 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Neuraminidase Inhibitor Sales Market Share by Application in 2021 & 2027 Figure 6. Hospital Pharmacies Examples Figure 7. Drug Stores Examples Figure 8. Retail Stores Examples Figure 9. Others Examples Figure 10. Global Neuraminidase Inhibitor Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Neuraminidase Inhibitor Sales Growth Rate (2016-2027) & (US$ Million) Figure 12. Global Neuraminidase Inhibitor Sales (K Units) Growth Rate (2016-2027) Figure 13. Global Neuraminidase Inhibitor Price Trends Growth Rate (2016-2027) (US$/Unit) Figure 14. Global Neuraminidase Inhibitor Revenue Market Share by Region: 2016 VS 2021 Figure 15. Global Neuraminidase Inhibitor Revenue Market Share by Region: 2021 VS 2027 Figure 16. North America Neuraminidase Inhibitor Revenue (Million USD) Growth Rate (2016-2027) Figure 17. North America Neuraminidase Inhibitor Sales (K Units) Growth Rate (2016-2027) Figure 18. Europe Neuraminidase Inhibitor Revenue (Million USD) Growth Rate (2016-2027) Figure 19. Europe Neuraminidase Inhibitor Sales (Million USD) Growth Rate (2016-2027) Figure 20. China Neuraminidase Inhibitor Revenue (Million USD) Growth Rate (2016-2027) Figure 21. China Neuraminidase Inhibitor Sales (Million USD) and Growth Rate (2016-2027) Figure 22. Japan Neuraminidase Inhibitor Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Japan Neuraminidase Inhibitor Sales (Million USD) Growth Rate (2016-2027) Figure 24. Southeast Asia Neuraminidase Inhibitor Revenue (Million USD) Growth Rate (2016-2027) Figure 25. Southeast Asia Neuraminidase Inhibitor Sales (Million USD) Growth Rate (2016-2027) Figure 26. India Neuraminidase Inhibitor Revenue (Million USD) Growth Rate (2016-2027) Figure 27. India Neuraminidase Inhibitor Sales (Million USD) Growth Rate (2016-2027) Figure 28. Global 5 Largest Neuraminidase Inhibitor Players Market Share by Revenue in Neuraminidase Inhibitor: 2016 & 2020 Figure 29. Neuraminidase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 30. Global Neuraminidase Inhibitor Revenue Share by Type (2016-2021) Figure 31. Global Neuraminidase Inhibitor Revenue Growth Rate by Type in 2016 & 2020 Figure 32. Global Neuraminidase Inhibitor Revenue Share by Application (2016-2021) Figure 33. Global Neuraminidase Inhibitor Revenue Growth Rate by Application in 2016 & 2020 Figure 34. North America Neuraminidase Inhibitor Sales Market Share by Type in 2020 Figure 35. North America Neuraminidase Inhibitor Sales Market Share by Application in 2020 Figure 36. Europe Neuraminidase Inhibitor Sales Market Share by Type in 2020 Figure 37. Europe Neuraminidase Inhibitor Sales Market Share by Application in 2020 Figure 38. China Neuraminidase Inhibitor Sales Market Share by Type in 2020 Figure 39. China Neuraminidase Inhibitor Sales Market Share by Application in 2020 Figure 40. Japan Neuraminidase Inhibitor Sales Market Share by Type in 2020 Figure 41. Japan Neuraminidase Inhibitor Sales Market Share by Application in 2020 Figure 42. Southeast Asia Neuraminidase Inhibitor Sales Market Share by Type in 2020 Figure 43. Southeast Asia Neuraminidase Inhibitor Sales Market Share by Application in 2020 Figure 44. India Neuraminidase Inhibitor Sales Market Share by Type in 2020 Figure 45. India Neuraminidase Inhibitor Sales Market Share by Application in 2020 Figure 46. Key Raw Materials Price Trend Figure 47. Manufacturing Cost Structure of Neuraminidase Inhibitor Figure 48. Manufacturing Process Analysis of Neuraminidase Inhibitor Figure 49. Neuraminidase Inhibitor Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

GlaxoSmithKline Gilead Sciences F. Hoffman-La Roche BioCryst Daiichi Sankyo